Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/efficacy-and-safety-of-etanercept-for-postoperative-pyoderma-0lhGlRNL7p
References (9)
-
(2019)
Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness -
Arhonowitz (2012)
Etiology and management of pyoderma gangrenosumA Comprehensive Review, 13
-
Jeremiah Miller, B. Yentzer, A. Clark, J. Jorizzo, S. Feldman (2010)
Pyoderma gangrenosum: a review and update on new therapies.Journal of the American Academy of Dermatology, 62 4
-
FIGURE 1 Pyoderma gangrenosum of the left breast before (a) and after etanercept treatment (b) -
P. Miheller, G. Műzes, G. Lakatos, E. Mihály, Z. Tulassay (2007)
Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.The Journal of emergency medicine, 32 2
-
Stanislav Tolkachjov, A. Fahy, D. Wetter, Kevin Brough, A. Bridges, M. Davis, R. El-Azhary, M. McEvoy, M. Camilleri (2015)
Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014.Journal of the American Academy of Dermatology, 73 4
-
I. Ahronowitz, J. Harp, K. Shinkai (2012)
Etiology and Management of Pyoderma GangrenosumAmerican Journal of Clinical Dermatology, 13
-
K. Zuo, Eric Fung, E. Tredget, A. Lin (2015)
A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy.Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 68 3
-
S. Vermeire, G. Assche, P. Rutgeerts (2009)
Serum sickness, encephalitis and other complications of anti-cytokine therapy.Best practice & research. Clinical gastroenterology, 23 1
- Publisher
- Wiley
- Copyright
- "© 2019 Wiley Periodicals, Inc."
- ISSN
- 1396-0296
- eISSN
- 1529-8019
- DOI
- 10.1111/dth.12774
- Publisher site
- See Article on Publisher Site
Abstract
Non‐peristomal postoperative pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that occurs in the early postoperative period at surgical incisions, most commonly after breast surgery. Early diagnosis and treatment is essential to prevent severe scaring. TNF‐alpha inhibitor infliximab was reported to be efficient in treatment of PPG refractory to systemic corticosteroids. However infliximab can be not well tolerated. We report the first case of etanercept efficacy in post‐plastic breast surgery pyoderma gangrenosum after infliximab serum sickness.
Journal
Dermatologic Therapy – Wiley
Published: Jan 1, 2019
Keywords: ; ;